" ( ) "

³ ( )

 (0)

 (0)

    
  1 / 1 |   | | viewdetails | |  
 # 84141
ò ˲ Բ
      (uk)     (ru)     (en)      
( 20 .)  䳺
(11) 84141 (51) (2006)
A61K 31/00
A61K 31/554 (2006.01)
A61P 1/10 (2006.01)
(24) 25.09.2008
(21) a200508758 (22) 01.04.2004
(31) 0307918.3
(32) 05.04.2003
(33) GB
(41) 15.12.2005, . 12
(46) 25.09.2008, . 18
(56) US 2002142054 A1, 03.10.2002
GB 2262888 A, 07.07.1993
WO 9901149 A, 14.01.1999
WO 03022286 A, 20.03.2003
WO 9316055 A, 19.08.1993
ALIMENTARY PHARMACOLOGY AND THERAPEUTICS 2001 UNITED KINGDOM, vol. 15, no. 6, 2001, pages 749-763
GASTROENTEROLOGY, vol. 98, no. 1, 1989, pages 25-32
(85) 05.11.2005
(86) PCT/GB2004/001396, 01.04.2004
(71) (SE )
...................................................................................................................................................................
(SE )
...................................................................................................................................................................
ALBIREO AB (SE )
(72) (SE ); ó - (SE )
...................................................................................................................................................................
(SE ); - (SE )
...................................................................................................................................................................
Abrahamsson Hasse Roland (SE ); Gillberg Per-Goran (SE )
(73) , Arvid Wallgrens Backe 20 SE-431 46 Goteborg, Sweden (SE )
...................................................................................................................................................................
(SE )
...................................................................................................................................................................
ALBIREO AB (SE )
(74)
(98) i Ii
. ̳, 4, . 39, . , 03151
(UA)
(54) ò ˲ Բ
...................................................................................................................................................................
USE OF I INHIBITOR IN TREATMENT AND/OR PROPHYLAXIS OF CONSTIPATION
...................................................................................................................................................................
(57)
   
 
0.644819974899